CXCL8 is a pro-inflammatory chemokine that acts on leukocytes and endothelial cells via their CXCR1 and CXCR2 receptors to promote immune infiltration and angiogenesis, which in turn establishes a venue for cancer cell local invasion, migration, and metastasis. Here, CXCL8 is linked to cancer.